4.1 Article

Graph neural networks for the identification of novel inhibitors of a small RNA

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Pharmacology & Pharmacy

Strategies for targeting RNA with small molecule drugs

Christopher L. Haga et al.

Summary: Traditionally, therapeutic treatment of disease has focused on targeting proteins, with RNA largely ignored as a druggable target. Recent studies suggest that only a small percentage of disease-associated proteins can be targeted with drugs.

EXPERT OPINION ON DRUG DISCOVERY (2023)

Article Biochemistry & Molecular Biology

High Expression Levels of miR-21-5p in Younger Hospitalized COVID-19 Patients Are Associated with Mortality and Critical Disease

Brandon Bautista-Becerril et al.

Summary: Increased expression levels of miR-21-5p are associated with the severity, invasive mechanical ventilation (IMV), and mortality of younger hospitalized COVID-19 patients.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Medicine, Research & Experimental

Delivery of anti-microRNA-21 by lung-targeted liposomes for pulmonary fibrosis treatment

Lingyue Yan et al.

Summary: Idiopathic pulmonary fibrosis (IPF), a chronic lung disorder, has a low survival rate. Pulmonary fibrosis is a common complication of COVID-19 and effective therapies are limited. MicroRNAs show potential as drug candidates for IPF treatment. A lung-targeted, cationic liposome formulation has been developed to deliver anti-miR-21 and reduce fibrosis progression.

MOLECULAR THERAPY-NUCLEIC ACIDS (2023)

Article Chemistry, Medicinal

Predicting Protein-Ligand Docking Structure with Graph Neural Network

Huaipan Jiang et al.

Summary: Modern drug discovery is costly and time-consuming. Computational approaches help reduce costs, but traditional software has low accuracy and high latency. MedusaGraph is a novel framework based on graph neural networks that generates docking poses directly and achieves 10 to 100 times speedup compared to current methods with slightly better accuracy.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2022)

Review Pharmacology & Pharmacy

Graph neural networks for automated de novo drug design

Jiacheng Xiong et al.

Summary: De novo drug design aims to create novel chemical entities with desired properties, with the recent popularity of data-driven methods utilizing artificial intelligence technologies like graph neural networks (GNNs). The applications of GNNs in drug design include molecule scoring, generation, optimization, and synthesis planning, with discussions on current challenges and future directions in this field.

DRUG DISCOVERY TODAY (2021)

Article Chemistry, Medicinal

Generative Models for De Novo Drug Design

Xiaochu Tong et al.

Summary: Generative models in the field of artificial intelligence have made remarkable achievements in drug design, covering various models and applications. Through generative models, compounds can be generated to expand the compound library, design compounds with specific properties, and use some publicly available tools to directly generate molecules.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Biochemical Research Methods

GraphDTA: predicting drug-target binding affinity with graph neural networks

Thin Nguyen et al.

Summary: Drug repurposing, finding new uses for already approved drugs, is a cost-effective approach to drug development. The GraphDTA model represents drugs as graphs and utilizes graph neural networks to predict drug-target affinity more effectively than non-deep learning models. This demonstrates the potential of deep learning models in predicting drug-target binding affinity and the benefits of representing drugs as graphs.

BIOINFORMATICS (2021)

Review Medical Informatics

Artificial intelligence in COVID-19 drug repurposing

Yadi Zhou et al.

LANCET DIGITAL HEALTH (2020)

Article Biochemistry & Molecular Biology

Systematic analysis of the interactions driving small molecule-RNA recognition

G. Padroni et al.

RSC MEDICINAL CHEMISTRY (2020)

Review Biochemistry & Molecular Biology

Molecular Docking: Shifting Paradigms in Drug Discovery

Luca Pinzi et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Chemistry, Medicinal

Graph Convolutional Neural Networks for Predicting Drug-Target Interactions

Wen Torng et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2019)

Article Biochemistry & Molecular Biology

Statistical and machine learning approaches to predicting protein-ligand interactions

Lucy J. Colwell

CURRENT OPINION IN STRUCTURAL BIOLOGY (2018)

Article Pharmacology & Pharmacy

Baicalein represses TGF-β1-induced fibroblast differentiation through the inhibition of miR-21

Xinjian Cui et al.

TOXICOLOGY AND APPLIED PHARMACOLOGY (2018)

Article Biochemistry & Molecular Biology

Small Molecule Inhibition of miR-544 Biogenesis Disrupts Adaptive Responses to Hypoxia by Modulating ATM-mTOR Signaling

Christopher L. Haga et al.

ACS CHEMICAL BIOLOGY (2015)

Article Medicine, General & Internal

Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

Luca Richeldi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Pharmacology & Pharmacy

Baicalein attenuates bleomycin-induced pulmonary fibrosis in rats through inhibition of miR-21

Yan Gao et al.

PULMONARY PHARMACOLOGY & THERAPEUTICS (2013)

Review Medical Laboratory Technology

MicroRNAs in idiopathic pulmonary fibrosis

Kusum V. Pandit et al.

TRANSLATIONAL RESEARCH (2011)

Article Immunology

miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis

Gang Liu et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2010)

Article Critical Care Medicine

Incidence and prevalence of idiopathic pulmonary fibrosis

Ganesh Raghu et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)

Article Computer Science, Artificial Intelligence

A fast and elitist multiobjective genetic algorithm: NSGA-II

K Deb et al.

IEEE TRANSACTIONS ON EVOLUTIONARY COMPUTATION (2002)